PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
02-Nov-2022 Stratasys Makes Strategic Investment in Axial3D Businesswire
02-Nov-2022 Bluestar Genomics Presents Positive Results From Validation Study in Pancreatic Cancer Detection at American Pancreatic Association (APA) Annual Meeting Businesswire
02-Nov-2022 Can-Fite: Positive New Data from it’s Phase III Psoriasis Study will be Presented Today at an Industry Expert Summit in Boston Businesswire
02-Nov-2022 2022 China Crop Protection China Monthly Report: Stay Ahead in the Fast-Changing Market With Real-Time Reporting on the Whole Industrial Chain - ResearchAndMarkets.com Businesswire
02-Nov-2022 BeiGene Receives European Commission Approval for BRUKINSA® (zanubrutinib) for the Treatment of Adults with Marginal Zone Lymphoma Businesswire
02-Nov-2022 KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
02-Nov-2022 Sense and Biotecom Agree to Distribute Rapid, Instrument-Free Molecular Test, Veros COVID-19 in Chile Businesswire
02-Nov-2022 Charles River Laboratories Announces Third-Quarter 2022 Results Businesswire
02-Nov-2022 Redwire Launching Upgraded 3D Bioprinter to Space Station to Investigate New Treatment to Aid Military Service Members, Expands Crop Production Research and Materials Testing on Orbit Businesswire
02-Nov-2022 Precision BioSciences to Report Third Quarter 2022 Financial Results on November 8, 2022 Businesswire
02-Nov-2022 OmniAb, Inc. to Ring Nasdaq Stock Market Opening Bell Businesswire
02-Nov-2022 Antibe Closes Previously Announced Strategic Sale of Citagenix Subsidiary Businesswire
02-Nov-2022 GlycoMimetics to Report Third Quarter Financial Results on November 9, 2022 Businesswire
02-Nov-2022 Data Reinforcing Impact of Bristol Myers Squibb Cardiovascular Portfolio to be Presented at American Heart Association Scientific Sessions 2022 Businesswire
02-Nov-2022 ROME Therapeutics and Enara Bio to Host Inaugural Dark Genome Symposium Convening Industry and Academic Leaders to Catalyze Therapeutic Application of Dark Genome Research Businesswire
02-Nov-2022 Lusaris Therapeutics Launches with $60 Million Series A Financing to Redefine the Treatment of Severe Neuropsychiatric and Neurological Disorders Businesswire
02-Nov-2022 Global Cannabis Testing Market to Grow at 16.5% Annually Through 2029 - ResearchAndMarkets.com Businesswire
02-Nov-2022 Transdermal Drug Delivery Market Analysis 2022: Technological Advances Present Lucrative Opportunities - ResearchAndMarkets.com Businesswire
02-Nov-2022 Oncovita presents preclinical data on its promising MVdeltaC oncolytic vaccine at SITC Annual Meeting 2022 Andrew Lloyd Associates
02-Nov-2022 MediClin AG: Group sales and Group operating result above previous year − stable capacity utilization, energy costs weigh on result MediClin AG